StockData
Dyadic International Inc logo

Dyadic International Inc (DYAI) stock

DYAINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$0.32+0.00 (+1.30%)

Close on Nov 18, 2026Market cap $11.66MP/E –Yield –

Dyadic International operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Dyadic International's operating cash flow for the twelve months ending Sep 30, 2026 was -$7.04M. For fiscal 2025 it was -$5.70M. The highest annual figure on record is -$1.69M in fiscal 2017.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$5.70M–
FY2024Dec 31, 2024-$3.97M–
FY2023Dec 31, 2023-$6.73M–
FY2022Dec 31, 2022-$8.08M–
FY2021Dec 31, 2021-$11.28M–
FY2020Dec 31, 2020-$6.57M–
FY2019Dec 31, 2019-$5.78M–
FY2018Dec 31, 2018-$4.41M–
FY2017Dec 31, 2017-$1.69M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$1.48M–
Q2 FY2026Jun 30, 2026-$1.82M–
Q1 FY2026Mar 31, 2026-$1.96M–
Q4 FY2025Dec 31, 2025-$1.77M–
Q3 FY2025Sep 30, 2025-$1.85M–
Q2 FY2025Jun 30, 2025-$130.02K–
Q1 FY2025Mar 31, 2025-$1.95M–
Q4 FY2024Dec 31, 2024-$696.40K–
Q3 FY2024Sep 30, 2024-$201.06K–
Q2 FY2024Jun 30, 2024-$1.96M–
Q1 FY2024Mar 31, 2024-$1.11M–
Q4 FY2023Dec 31, 2023-$923.38K–
Q3 FY2023Sep 30, 2023-$1.96M–
Q2 FY2023Jun 30, 2023-$1.65M–
Q1 FY2023Mar 31, 2023-$2.19M–
Q4 FY2022Dec 31, 2022-$1.68M–
Q3 FY2022Sep 30, 2022-$1.78M–
Q2 FY2022Jun 30, 2022-$1.78M-100.1%
Q1 FY2022Mar 31, 2022-$2.85M–
Q4 FY2021Dec 31, 2021-$2.64M–
Q3 FY2021Sep 30, 2021-$4.33M–
Q2 FY2021Jun 30, 2021$1.90B–
Q1 FY2021Mar 31, 2021-$1.91B–
Q4 FY2020Dec 31, 2020-$1.29M–
Q3 FY2020Sep 30, 2020-$1.38M–
Q2 FY2020Jun 30, 2020-$1.91M–
Q1 FY2020Mar 31, 2020-$2.00M–
Q4 FY2019Dec 31, 2019-$1.40M–
Q3 FY2019Sep 30, 2019-$1.54M–
Q2 FY2019Jun 30, 2019-$1.43M–
Q1 FY2019Mar 31, 2019-$1.41M–
Q4 FY2018Dec 31, 2018-$1.23M–
Q3 FY2018Sep 30, 2018-$801.34K–
Q2 FY2018Jun 30, 2018-$1.72M–
Q1 FY2018Mar 31, 2018-$660.76K–

More Dyadic International figures

See a number that looks wrong?